Deprescribing Type 2 Diabetes Mellitus Medications in Older Adults in an Urban Primary Care Setting

Presenter Information

Katelyn Koons, MD, Thomas Jefferson University Hospital
Eugenie Hughes, MD, Thomas Jefferson University Hospital
Eunice Choe, MD, Thomas Jefferson University HospitalFollow
Julio Garcia, MD, Thomas Jefferson University HospitalFollow
Munifa King, MD, Thomas Jefferson University HospitalFollow
Emily Lavell, MD, Thomas Jefferson University HospitalFollow
Michael Danielewicz, MD, Thomas Jefferson UniversityFollow

Start Date

5-15-2025 9:30 AM

End Date

5-15-2025 11:30 AM

Description

Background

• Adults 65+ take on average five medications daily
• Polypharmacy increases risks of drug interactions and adverse events
• About 29% adults 65+ in developed countries have type 2 diabetes mellitus (T2DM) and the number of older adults living with these conditions is expected to increase rapidly in the coming decades
• Over-treatment of DM in older adults is common and increases risks of serios adverse outcomes including hypoglycemia
• Older adults with T2DM should have higher A1c goal consistent with ADA guidelines: [See Table on Poster]

Keywords

geriatrics, deprescribing

Comments

Presented at the 2025 Jefferson Health Equity and Quality Improvement (HEQI) Summit.